FDA enforcement records identify Straumann USA LLC, at 60 Minuteman Rd, Andover, Massachusetts, as the firm behind a Class II recall of GM Helix Implant, REF 109.984. The same record gives lot VZPF4, a quantity of 216 units, and nationwide distribution across 24 named states. A separate FDA page lists a Class 2 Device Recall for GM Helix Implant with a firm-initiated date of July 13, 2026. These are filing identities and dates, not measures of product performance or company-wide safety. [1][2][6]

The recall record and its stated scope

The enforcement entry for recall number Z-3173-2026 states that a discrepancy exists between the product identification on the packaging and the dimensions of the implant inside. The record classifies the action as Class II, describes it as voluntary and firm initiated, and notes that the initial notification was a letter. The report date is September 23, 2026, the center classification date is September 15, 2026, and the recall initiation date is August 12, 2026. [1]

Distribution is described as nationwide in Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Kansas, Louisiana, Massachusetts, Michigan, Missouri, North Carolina, New Jersey, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, Virginia and Wisconsin. The code information ties the affected units to REF 109.984, a UDI string and lot VZPF4. The FDA database page for the same product name carries the Class 2 Device Recall label and a July 13, 2026 firm-initiated date, which differs from the August 12, 2026 initiation date in the enforcement entry. [1][2][6]

Clearance scope for GM Helix implants

An FDA clearance letter dated December 12, 2025 addresses submission K252090, titled Pterygoid Indication for GM Helix Implants, under regulation 21 CFR 872.3640 for endosseous dental implants in Class II, product codes DZE and NHA. The letter is addressed to JJGC Indústria e Comércio de Materiais Dentários S.A. care of a regulatory affairs contact at Straumann USA, LLC in Andover, Massachusetts. That address is a filing address, not a verified headquarters. [4]

The letter states that the purpose of the submission is the addition of a pterygoid indication and that the implants and abutments keep the same design and features cleared in the original submission. It also states that the subject devices have equivalent indications for use to the primary predicate K212785. This identifies JJGC as the applicant for that clearance and Straumann USA as the correspondence contact, a distinction worth keeping when reading the record. [4]

Brand documentation and product identity

Neodent material published on Straumann websites describes Neodent as a Straumann Group brand and lists Helix GM among its trademarks, alongside Grand Morse, Drive GM, Titamax GM, Helix, Drive and Titamax. The 2026 Neodent product catalog describes Neodent as a global brand founded by a dentist for dentists, available in 95 countries with a legacy of more than 30 years, and directs readers to the product label for the recognized legal manufacturer. [3][5][7]

A Straumann eShop listing for REF 109.945 shows a GM Helix Implant in titanium at 3.5 by 11.5 mm, marked sterile, with a 3.5 mm implant diameter and a Helix implant body. That reference differs from the REF 109.984 named in the recall, so the listing documents the product family rather than the affected lot. The catalog footer gives Straumann USA, LLC at 60 Minuteman Road, Andover, MA 01810 as the North American headquarters contact. [7][9]

What the records do and do not establish

The linked collection for this profile contains no portfolio records, so no decision counts or pathway totals are available to describe. The recall entry and the clearance letter are separate documents with different roles: one records a field action by Straumann USA LLC, the other records a clearance held by JJGC with Straumann USA named as contact. Neither document establishes sales volumes, market share, clinical outcomes or the full extent of the product line. [1][4]

An FDA search page keyed to 510(k) number K163194 returns six results without further detail in the retrieved text, and the remaining database pages provide navigation and language-access material rather than product facts. Questions about the legal manufacturer for specific references, current availability of REF 109.984, or the resolution of the recall remain unanswered by these records. [2][6][8]